4DMedical Ltd
ASX:4DX

Watchlist Manager
4DMedical Ltd Logo
4DMedical Ltd
ASX:4DX
Watchlist
Price: 0.445 AUD -2.2%
Market Cap: 183m AUD
Have any thoughts about
4DMedical Ltd?
Write Note

4DMedical Ltd
Total Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

4DMedical Ltd
Total Current Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
4DMedical Ltd
ASX:4DX
Total Current Liabilities
AU$21.9m
CAGR 3-Years
39%
CAGR 5-Years
49%
CAGR 10-Years
N/A
Mach7 Technologies Ltd
ASX:M7T
Total Current Liabilities
AU$15.1m
CAGR 3-Years
26%
CAGR 5-Years
24%
CAGR 10-Years
67%
CogState Ltd
ASX:CGS
Total Current Liabilities
$12.6m
CAGR 3-Years
-13%
CAGR 5-Years
7%
CAGR 10-Years
21%
Pro Medicus Ltd
ASX:PME
Total Current Liabilities
AU$34.6m
CAGR 3-Years
25%
CAGR 5-Years
20%
CAGR 10-Years
19%
Medibio Ltd
ASX:MEB
Total Current Liabilities
AU$1.8m
CAGR 3-Years
8%
CAGR 5-Years
-19%
CAGR 10-Years
N/A
Medadvisor Ltd
ASX:MDR
Total Current Liabilities
AU$45.7m
CAGR 3-Years
25%
CAGR 5-Years
N/A
CAGR 10-Years
61%
No Stocks Found

4DMedical Ltd
Glance View

Market Cap
182.6m AUD
Industry
Health Care

4DMedical Ltd. is a software technology company, which commercializes four-dimensional lung imaging platform called XV Technology. The company is headquartered in Melbourne, Victoria. The company went IPO on 2020-08-07. The firm is focused on development of a non-invasive respiratory imaging solution using four-dimensional imaging. The firm's XV Technology is a four-dimensional lung imaging technology that utilizes mathematical models and algorithms to convert X-ray scans into quantitative data for physicians to manage patients with respiratory diseases and diseases of the lung. The XV Technology is accessible through a cloud-based software as a service (SaaS) platform that integrates with existing hospital equipment. The XV Technology Lung Ventilation Analysis Software (XV LVAS Ventilation) provides a non-invasive way of understanding regional lung motion and airflow. The company enables physicians to detect areas of high and low ventilation from all parts of the lung, in all phases of the breath.

4DX Intrinsic Value
0.467 AUD
Undervaluation 5%
Intrinsic Value
Price

See Also

What is 4DMedical Ltd's Total Current Liabilities?
Total Current Liabilities
21.9m AUD

Based on the financial report for Jun 30, 2024, 4DMedical Ltd's Total Current Liabilities amounts to 21.9m AUD.

What is 4DMedical Ltd's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 5Y
49%

Over the last year, the Total Current Liabilities growth was 28%. The average annual Total Current Liabilities growth rates for 4DMedical Ltd have been 39% over the past three years , 49% over the past five years .

Back to Top